Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Journal of the American Academy of Dermatology
|
March 27, 2022
Further analysis of skin of color representation in dermatology textbooks used by residents
Taylor Harp, Michelle Militello, Victoria McCarver, et al.
Cureus
|
March 30, 2026
A Pilot Convenience Survey of Clinicians' Perception of the Desirability of a Lower Dose Option of an Opioid Analgesic: Hydrocodone as an Example
Claudio S Pergolizzi, Joseph V Pergolizzi, Thomas Harrison, et al.
BMC Infectious Diseases
|
August 1, 2021
Neurological deterioration in a patient with HIV-associated cryptococcal meningitis initially improving on antifungal treatment: a case report of coincidental racemose neurocysticercosis
Newton Kalata, Jayne Ellis, Laura Benjamin, et al.
Frontiers in Immunology
|
December 22, 2023
Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity
Emil Joseph Vergara, Andy Cano Tran, Mi-Young Kim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 15, 2009
Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study
Tihana Bicanic, Graeme Meintjes, Kevin Rebe, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2017
Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria
Yingjun Liu, Henry Pertinez, Fatima Ortega-Muro, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2017
Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis
Jodi Lestner, Laura McEntee, Adam Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2008
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial
Tihana Bicanic, Robin Wood, Graeme Meintjes, et al.
Journal of Clinical Microbiology
|
March 24, 2017
Targeted Enrichment for Pathogen Detection and Characterization in Three Felid Species
Justin S Lee, Ryan S Mackie, Thomas Harrison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2018
Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus-infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis
Elvis Temfack, Jean Joel Bigna, Henry N Luma, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Journal of the American Academy of Dermatology
|
March 27, 2022
Further analysis of skin of color representation in dermatology textbooks used by residents
Taylor Harp, Michelle Militello, Victoria McCarver, et al.
Cureus
|
March 30, 2026
A Pilot Convenience Survey of Clinicians' Perception of the Desirability of a Lower Dose Option of an Opioid Analgesic: Hydrocodone as an Example
Claudio S Pergolizzi, Joseph V Pergolizzi, Thomas Harrison, et al.
BMC Infectious Diseases
|
August 1, 2021
Neurological deterioration in a patient with HIV-associated cryptococcal meningitis initially improving on antifungal treatment: a case report of coincidental racemose neurocysticercosis
Newton Kalata, Jayne Ellis, Laura Benjamin, et al.
Frontiers in Immunology
|
December 22, 2023
Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity
Emil Joseph Vergara, Andy Cano Tran, Mi-Young Kim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 15, 2009
Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study
Tihana Bicanic, Graeme Meintjes, Kevin Rebe, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2017
Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria
Yingjun Liu, Henry Pertinez, Fatima Ortega-Muro, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2017
Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis
Jodi Lestner, Laura McEntee, Adam Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2008
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial
Tihana Bicanic, Robin Wood, Graeme Meintjes, et al.
Journal of Clinical Microbiology
|
March 24, 2017
Targeted Enrichment for Pathogen Detection and Characterization in Three Felid Species
Justin S Lee, Ryan S Mackie, Thomas Harrison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2018
Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus-infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis
Elvis Temfack, Jean Joel Bigna, Henry N Luma, et al.
Page
of 5